2LL-28862-50577
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 232 / VA
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- YRE-20157-00406
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-29
Registered in v-safe
- 2022-06-29
- 2022-06-30
- 2022-07-07
-
2022-07-14
Dose 2 — Pfizer-BioNTech
- 2022-07-23
-
2022-07-28
Survey response — day 14, dose 2, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
- 2022-08-11
- 2022-08-18
- 2022-08-25
- 2022-10-13
- 2023-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-07-14 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release